# Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm

> **NCT05359224** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 406 (estimated)

## Conditions studied

- Intracranial Aneurysm

## Interventions

- **DRUG:** Prasugrel group
- **DRUG:** Clopidogrel group

## Key facts

- **NCT ID:** NCT05359224
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-13
- **Primary completion:** 2025-07
- **Final completion:** 2025-08
- **Target enrollment:** 406 (ESTIMATED)
- **Last updated:** 2022-07-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05359224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05359224, "Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05359224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*